RESIDUES IN POCKET-B AND POCKET-F OF HLA-B27 ARE CRITICAL IN THE PRESENTATION OF AN INFLUENZA-A VIRUS NUCLEOPROTEIN PEPTIDE AND INFLUENCE THE STABILITY OF PEPTIDE - MHC COMPLEXES

被引:28
作者
CARRENO, BM
WINTER, CC
TAUROG, JD
HANSEN, TH
BIDDISON, WE
机构
[1] WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110
[2] NINCDS,NEUROIMMUNOL BRANCH,MOLEC IMMUNOL SECT,BETHESDA,MD 20892
[3] UNIV TEXAS,SW MED CTR,HAROLD C SIMMONS ARTHRITIS RES CTR,DALLAS,TX 75235
[4] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235
关键词
ANTIGEN PRESENTATION; HLA-B27; MHC CLASS-I;
D O I
10.1093/intimm/5.4.353
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Six pockets, designated A through F, which extend from the peptide binding site of class I HLA molecules, have been postulated to play an important role in determining peptide binding specificity. HLA-B27 mutant molecules with single amino acid substitutions at residues 9his-->phe, 24thr-->ser, 45glu-->thr, and 67cys-->ala in pocket B; 114his-->asn in pocket D; and 116asp-->phe in pocket F have been generated and characterized for their capacity to present an influenza A nucleoprotein peptide (NP 383 - 391) for cytotoxic T lymphocyte recognition. We report here that substitutions in residues 45, 67, and 116 affect presentation of NP 383 - 391 when peptide is processed and loaded during viral infection. Using I-125-labeled NP peptide, we demonstrate that substitutions in residues 67 and 116 alter the stability of NP - HLA-B27 complexes. A substitution at position 9 of the NP peptide complements the mutation introduced at residue 116, suggesting that the NP peptide binds with its carboxy terminal amino acid in pocket F. These findings indicate that polymorphic residues within pockets B and F of HLA-B27 play a crucial role in peptide binding and stability of peptide - MHC class I complexes. Furthermore, our results suggest that substitutions at allele-specific residues within pockets B and F alter the stability of NP - HLA-B27 complexes resulting in the diminution or abrogation of NP presentation during viral infection.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 42 条
  • [1] PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS
    BARNSTABLE, CJ
    BODMER, WF
    BROWN, G
    GALFRE, G
    MILSTEIN, C
    WILLIAMS, AF
    ZIEGLER, A
    [J]. CELL, 1978, 14 (01) : 9 - 20
  • [2] PEPTIDE BINDING TO EMPTY HLA-B27 MOLECULES OF VIABLE HUMAN-CELLS
    BENJAMIN, RJ
    MADRIGAL, JA
    PARHAM, P
    [J]. NATURE, 1991, 351 (6321) : 74 - 77
  • [3] BIDDISON WE, 1980, J IMMUNOL, V124, P548
  • [4] THE FOREIGN ANTIGEN-BINDING SITE AND T-CELL RECOGNITION REGIONS OF CLASS-I HISTOCOMPATIBILITY ANTIGENS
    BJORKMAN, PJ
    SAPER, MA
    SAMRAOUI, B
    BENNETT, WS
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1987, 329 (6139) : 512 - 518
  • [5] CLASS-I CROSS-RESTRICTED T-CELLS REVEAL LOW RESPONDER ALLELE DUE TO PROCESSING OF VIRAL-ANTIGEN
    BODMER, HC
    GOTCH, FM
    MCMICHAEL, AJ
    [J]. NATURE, 1989, 337 (6208) : 653 - 655
  • [6] ANCHORING POCKETS IN HUMAN HISTOCOMPATIBILITY COMPLEX LEUKOCYTE ANTIGEN (HLA) CLASS-I MOLECULES - ANALYSIS OF THE CONSERVED B-(45)-POCKET OF HLA-B27
    BUXTON, SE
    BENJAMIN, RJ
    CLAYBERGER, C
    PARHAM, P
    KRENSKY, AM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) : 809 - 820
  • [7] THE PEPTIDE BINDING-SPECIFICITY OF HLA CLASS-I MOLECULES IS LARGELY ALLELE-SPECIFIC AND NONOVERLAPPING
    CARRENO, BM
    KOENIG, S
    COLIGAN, JE
    BIDDISON, WE
    [J]. MOLECULAR IMMUNOLOGY, 1992, 29 (09) : 1131 - 1140
  • [8] HLA-B37 AND HLA-A2.1 MOLECULES BIND LARGELY NONOVERLAPPING SETS OF PEPTIDES
    CARRENO, BM
    ANDERSON, RW
    COLIGAN, JE
    BIDDISON, WE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) : 3420 - 3424
  • [9] PEPTIDE BINDING TO CLASS-I MHC ON LIVING CELLS AND QUANTITATION OF COMPLEXES REQUIRED FOR CTL LYSIS
    CHRISTINCK, ER
    LUSCHER, MA
    BARBER, BH
    WILLIAMS, DB
    [J]. NATURE, 1991, 352 (6330) : 67 - 70
  • [10] CULLEN SE, 1976, J IMMUNOL, V117, P136